Adicon Holdings (HKSE:09860) Growth Rank : 0 (As of Jun. 06, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Adicon Holdings Growth Rank?

Adicon Holdings has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Adicon Holdings Growth Rank Related Terms

Thank you for viewing the detailed overview of Adicon Holdings's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Adicon Holdings (HKSE:09860) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (HKSE:09860) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

ADCNF:USA

Address

No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN

Website

https://www.adicon.com.cn

Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.

Executives

Cap V General Partner, L.p.	2201 Interest of corporation controlled by you
Cap V, L.l.c.	2201 Interest of corporation controlled by you
Carlyle Asia Partners V, L.p.	2201 Interest of corporation controlled by you
Carlyle Holdings Ii Gp L.l.c.	2201 Interest of corporation controlled by you
Carlyle Holdings Ii L.l.c.	2201 Interest of corporation controlled by you
Cg Subsidiary Holdings L.l.c.	2201 Interest of corporation controlled by you
Pearl Group Limited	2101 Beneficial owner
Tc Group Cayman Investment Holdings L.p.	2201 Interest of corporation controlled by you
Tc Group Cayman Investment Holdings Sub L.p.	2201 Interest of corporation controlled by you
The Carlyle Group Inc.	2201 Interest of corporation controlled by you
Lin Feng
Mega Stream Limited
Trident Trust Company (hk) Limited	2301 Trustee
Ingenuity Capital Holdings Limited	2201 Interest of corporation controlled by you
Corelink Group Limited

Adicon Holdings (HKSE:09860) Headlines

No Headlines